Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corifollitropin Alfa + hpHMG for Poor Ovarian Responders
NCT01732068Phase 2Completed
- Sponsor
- UZ Brussel
- Start
- Jul 2012
- Primary completion
- May 2013
- Modality
- rProtein (Recombinant Protein), Hormone, Biologic
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of corifollitropin alfa in poor ovarian response (POR), sponsored by UZ Brussel. Primary endpoint: Ongoing pregnancy rate. Started Jul 2012; status: completed.
02
Drugs
corifollitropin alfa
03
Conditions
poor ovarian response (POR)
Beyond the preview
Go deeper on NCT01732068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01732068.